Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 12Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Carcinoma, Hepatocellular 11Stomach Neoplasms 6Neoplasms 5Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Myositis 2Lung Neoplasms 2Cholangiocarcinoma 2Vascular Complications 1Sjogren's Syndrome 1Scleroderma, Systemic 1Sarcopenia 1Recurrence 1Rectal Neoplasms 1Plaque, Atherosclerotic 1Pathologic Complete Response 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Metastatic Colorectal Adenocarcinoma 1Melanoma 1Lupus Erythematosus, Systemic 1Lung Diseases, Interstitial 1Liver Neoplasms 1Influenza, Human 1Immune-Related Adverse Events 1

Interventions

Esophagectomy 13Blood Specimen Collection 10Surgical Procedures, Operative 8Radiotherapy 8Surveys and Questionnaires 5Endoscopic Mucosal Resection 5Drug Therapy 5Biopsy 5Specimen Handling 4Neoadjuvant Therapy 4Tissue Banks 3Psychiatric Rehabilitation 3Positron Emission Tomography Computed Tomography 3Polymerase Chain Reaction 3Observation 3Magnetic Resonance Spectroscopy 3Immunotherapy 3Immunohistochemistry 3Endoscopy 3Endoscopic Ultrasound-Guided Fine Needle Aspiration 3Diffusion Magnetic Resonance Imaging 3Breath Tests 3anlotinib 2Stents 2Quality of Life 2Platinum Compounds 2Paclitaxel 2Microarray Analysis 2Mass Screening 2Gastroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Esophageal Neoplasms × Immune Checkpoint Inhibitors × Clear all
NCT06889402 2025-03-21

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
600 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response, Esophageal Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡